Through clinical research studies, we offer patients access to some of the latest therapies, drugs and cutting-edge strategies. Some areas of current research involving esophageal and other gastrointestinal cancers include:
Any new treatment undergoes years, even decades, of study. Clinical studies, which involve people, encompass the final phases of cancer treatment research. Participating in a clinical study may be an important treatment option for many patients, who may be among the first to benefit from a new drug or therapy. About 50 percent of our patients are eligible for a clinical study. Whether or not you choose to participate is entirely your choice. Learn more about studies involving esophageal cancer.
Roswell Park is a leader in developing treatment programs that are individualized to each patient depending on the patient and tumor characteristics. Our Center for Personalized Medicine facilitates interaction with our clinical team to provide this state-of-the-art treatment planning.
We offer genetic testing, molecular profiling, tumor banking and other testing that contribute to the exploration of novel treatment options for this aggressive cancer. Although this is still in the research phase for esophageal cancer, there is progress every day.